137 results
6-K
EX-99
BLRX
Bioline Rx Ltd
24 Feb 14
BioLineRx Appoints Dr. Sandra Panem to
12:00am
and life sciences industries in the U.S. Her experience encompasses corporate and financial strategy, corporate governance, venture capital … in healthcare strategy, technology assessment and capital markets experience, and we expect that she will add great value to our Company as we
6-K
EX-99
BLRX
Bioline Rx Ltd
16 Jun 22
BioLineRx Announces Appointment of Commercial Strategy
7:05am
For Immediate Release
BioLineRx Announces Appointment of Commercial Strategy
and Operations Veteran Holly W. May as
Chief Commercial Officer … the company’s global commercial organization and over-arching commercial capabilities, inclusive of driving the development and execution of commercial strategy
6-K
EX-99
BLRX
Bioline Rx Ltd
12 Dec 14
BioLineRx Presents Multi-Year Clinical Development
12:00am
- Clinical trials in three additional indications for BL-8040 to be initiated in 2015 -
- Development strategy presented today at BioLineRx … regarding its multi-year clinical development strategy for BL-8040. The event will also include a keynote presentation by Dr. Jorge Cortes
6-K
EX-99
BLRX
Bioline Rx Ltd
15 Aug 12
BioLineRx Reports Second Quarter 2012 Results
12:00am
equal to approximately NIS 34.0 million ($8.7 million) for terminated programs. We are not required to repay loans for terminated programs. Our strategy … sites in Romania and India. Concurrent with the conduct of the trial and in accordance with our business strategy, we have continued to hold
6-K
EX-99
3pvcfn xg93
28 Nov 11
BioLineRx Reports Third Quarter 2011 Financial Results
12:00am
6-K
EX-99
5w7lw hqu30du
23 Mar 15
BioLineRx Reports Year End 2014 Financial Results
12:00am
6-K
EX-99
krh2ch
22 Mar 12
BioLineRx Reports Fourth Quarter and Calendar 2011 Results
12:00am
6-K
EX-99
3ga03nj
16 Aug 22
BioLineRx Reports Second Quarter 2022 Financial Results
7:19am
F-1
EX-10.17
01b 55g22h
24 Sep 10
Registration statement (foreign)
12:00am
6-K
EX-99
r0c2qxhelv6ovbkb
14 May 19
BioLineRx Reports First Quarter 2019 Financial Results
7:00am
6-K
EX-99
tpk5d3om
6 Aug 19
BioLineRx Reports Second Quarter 2019 Financial Results
7:11am
20FR12B
EX-4.17
qyn eelbvh
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
6-K
EX-99
gxpk6um72
20 May 20
BioLineRx Reports First Quarter 2020 Financial Results
7:00am
6-K
EX-99
rxcrk3xs
26 May 21
BioLineRx Reports First Quarter 2021 Financial Results
7:54am
6-K
EX-99
yicrs yxf9
16 Aug 22
BioLineRx Reports Second Quarter 2022 Financial Results
7:19am
6-K
EX-99
t27f7 3woe
23 Jan 12
BioLineRx Signs Exclusive License Agreement
12:00am
6-K
EX-99
hdyfiz01ropkp qlx2
24 Sep 12
BioLineRx Receives Notice of Allowance from USPTO
12:00am
6-K
EX-99
d33igayxf2svf8i
11 May 22
BioLineRx Reports First Quarter 2022 Financial Results
7:14am
6-K
EX-99
eoanm76pig3
18 Aug 21
BioLineRx Reports Second Quarter 2021 Financial Results
7:01am